Report Highlights
A recent market study published by FMI on Postoperative Nausea and Vomiting (PONV) Management offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Treatment Type:
- Serotonin Antagonists
- Steroids
- Dopamine Antagonists
- Neurokinin NK-1 Receptor Antagonists
- Non-pharmacological Treatment
By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies and Drug Stores
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Report Chapters
Executive Summary
The executive summary of the Postoperative Nausea and Vomiting (PONV) Management Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Postoperative Nausea and Vomiting (PONV) Management Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Postoperative Nausea and Vomiting (PONV) Management Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Treatment Type processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Postoperative Nausea and Vomiting (PONV) Management Market Demand Analysis 2018-2022 and Forecast, 2023-2033
The chapter include historical market value (US$ 1.04 Billion) analysis (2018-2022) and current and future market value (US$ 1.17 Billion) and volume (12.8%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Postoperative Nausea and Vomiting (PONV) Management Market - Pricing Analysis
Based on By Treatment Type, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033, By Treatment Type
Based on By Treatment Type, Postoperative Nausea and Vomiting (PONV) Management Market is segmented into Serotonin Antagonists, Steroids, Dopamine Antagonists, Neurokinin NK-1 Receptor Antagonists, Non-pharmacological Treatment. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Treatment Type.
Chapter 06 - Global Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
Based on By Distribution Channel, Postoperative Nausea and Vomiting (PONV) Management Market is segmented into Hospital Pharmacies, Online Pharmacies, Retail Pharmacies and Drug Stores. This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.
Chapter 07 - Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033, By Region
Based on By Region, Postoperative Nausea and Vomiting (PONV) Management Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 08 - North America Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 09 - Latin America Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Postoperative Nausea and Vomiting (PONV) Management Market in the Latin America region.
Chapter 10 - Europe Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Postoperative Nausea and Vomiting (PONV) Management Market in the regional market.
Chapter 11 - East Asia Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Postoperative Nausea and Vomiting (PONV) Management Market in the regional market.
Chapter 12 - South Asia Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Postoperative Nausea and Vomiting (PONV) Management Market in the regional market.
Chapter 13 - Middle East and Africa Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Postoperative Nausea and Vomiting (PONV) Management Market in the regional market.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2023 |
| Forecast period considered | 2023-2033 |
| Units considered | $ Million |
| Segments covered | By Treatment Type, By Distribution Channel, By Region |
| Industry covered | Healthcare |
| Countries covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
| Companies studied |
|
Chapter 14 - Key Countries Postoperative Nausea and Vomiting (PONV) Management Market Analysis 2018-2022 and Forecast 2023-2033
This chapter offers insights into how the Postoperative Nausea and Vomiting (PONV) Management Market is expected to grow in major countries globally.
Chapter 15 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 16 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Treatment Type portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Acacia Pharma, Hoffmann-La Roche AG, Novartis AG, Ani Pharmaceuticals, Inc, Camurus AB, Sanofi S.A., Helsinn Holding S.A., Eisai Corporation, Merck and Co., GlaxoSmithKline Corporation.
Chapter 17 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.
Chapter 18 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Postoperative Nausea and Vomiting (PONV) Management Market.
- Table 1 : Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
- Table 2 : Global Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 3 : Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Table 4 : North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
- Table 5 : North America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 6 : North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Table 7 : Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
- Table 8 : Latin America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 9 : Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Table 10 : Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
- Table 11 : Europe Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 12 : Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Table 13 : South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
- Table 14 : South Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 15 : South Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Table 16 : East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
- Table 17 : East Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 18 : East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Table 19 : Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
- Table 20 : Oceania Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 21 : Oceania Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Table 22 : MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
- Table 23 : MEA Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033
- Table 24 : MEA Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
- Figure 1 : Global Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 2 : Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 3 : Global Market Value (US$ Million) by Region, 2023 to 2033
- Figure 4 : Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
- Figure 5 : Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
- Figure 6 : Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
- Figure 7 : Global Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 8 : Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 9 : Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 10 : Global Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 11 : Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 12 : Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 13 : Global Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 14 : Global Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 15 : Global Market Attractiveness by Region, 2023 to 2033
- Figure 16 : North America Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 17 : North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 18 : North America Market Value (US$ Million) by Country, 2023 to 2033
- Figure 19 : North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
- Figure 20 : North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
- Figure 21 : North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
- Figure 22 : North America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 23 : North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 24 : North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 25 : North America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 26 : North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 27 : North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 28 : North America Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 29 : North America Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 30 : North America Market Attractiveness by Country, 2023 to 2033
- Figure 31 : Latin America Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 32 : Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 33 : Latin America Market Value (US$ Million) by Country, 2023 to 2033
- Figure 34 : Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
- Figure 35 : Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
- Figure 36 : Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
- Figure 37 : Latin America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 38 : Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 39 : Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 40 : Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 41 : Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 42 : Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 43 : Latin America Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 44 : Latin America Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 45 : Latin America Market Attractiveness by Country, 2023 to 2033
- Figure 46 : Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 47 : Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 48 : Europe Market Value (US$ Million) by Country, 2023 to 2033
- Figure 49 : Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
- Figure 50 : Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
- Figure 51 : Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
- Figure 52 : Europe Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 53 : Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 54 : Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 55 : Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 56 : Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 57 : Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 58 : Europe Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 59 : Europe Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 60 : Europe Market Attractiveness by Country, 2023 to 2033
- Figure 61 : South Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 62 : South Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 63 : South Asia Market Value (US$ Million) by Country, 2023 to 2033
- Figure 64 : South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
- Figure 65 : South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
- Figure 66 : South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
- Figure 67 : South Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 68 : South Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 69 : South Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 70 : South Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 71 : South Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 72 : South Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 73 : South Asia Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 74 : South Asia Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 75 : South Asia Market Attractiveness by Country, 2023 to 2033
- Figure 76 : East Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 77 : East Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 78 : East Asia Market Value (US$ Million) by Country, 2023 to 2033
- Figure 79 : East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
- Figure 80 : East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
- Figure 81 : East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
- Figure 82 : East Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 83 : East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 84 : East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 85 : East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 86 : East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 87 : East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 88 : East Asia Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 89 : East Asia Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 90 : East Asia Market Attractiveness by Country, 2023 to 2033
- Figure 91 : Oceania Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 92 : Oceania Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 93 : Oceania Market Value (US$ Million) by Country, 2023 to 2033
- Figure 94 : Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
- Figure 95 : Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
- Figure 96 : Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
- Figure 97 : Oceania Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 98 : Oceania Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 99 : Oceania Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 100 : Oceania Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 101 : Oceania Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 102 : Oceania Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 103 : Oceania Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 104 : Oceania Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 105 : Oceania Market Attractiveness by Country, 2023 to 2033
- Figure 106 : MEA Market Value (US$ Million) by Treatment Type, 2023 to 2033
- Figure 107 : MEA Market Value (US$ Million) by Distribution Channel, 2023 to 2033
- Figure 108 : MEA Market Value (US$ Million) by Country, 2023 to 2033
- Figure 109 : MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
- Figure 110 : MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
- Figure 111 : MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
- Figure 112 : MEA Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033
- Figure 113 : MEA Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033
- Figure 114 : MEA Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033
- Figure 115 : MEA Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
- Figure 116 : MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
- Figure 117 : MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
- Figure 118 : MEA Market Attractiveness by Treatment Type, 2023 to 2033
- Figure 119 : MEA Market Attractiveness by Distribution Channel, 2023 to 2033
- Figure 120 : MEA Market Attractiveness by Country, 2023 to 2033
Future Market Insights is the premier provider of market intelligence and consulting services, serving client in over 160 countries. FMI is headquartered in London, the global financial capital and has delivery centers in the U.S. and India. FMI's research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure that our clients prepare for the evolving needs of their customers. FMI's team of over 200 research analysts provides market intelligence at global, regional, and country levels. Our analysts are committed to provide independent insights, relying on our cognitive training modules, which conditions them to look at data objectively and unbiasedly. Others you can use from the file Allen just shared when those will be made live.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More